Form 8-K - Current report:
SEC Accession No. 0001193125-24-193906
Filing Date
2024-08-05
Accepted
2024-08-05 16:10:54
Documents
17
Period of Report
2024-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d879198d8k.htm   iXBRL 8-K 31213
2 EX-99.1 d879198dex991.htm EX-99.1 47582
3 EX-99.2 d879198dex992.htm EX-99.2 11396
7 GRAPHIC g879198dsp01a.jpg GRAPHIC 2955
8 GRAPHIC g879198dsp9.jpg GRAPHIC 4039
  Complete submission text file 0001193125-24-193906.txt   237242

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA etnb-20240730.xsd EX-101.SCH 2843
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20240730_lab.xml EX-101.LAB 17993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20240730_pre.xml EX-101.PRE 11256
19 EXTRACTED XBRL INSTANCE DOCUMENT d879198d8k_htm.xml XML 3633
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 241174863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)